574 related articles for article (PubMed ID: 9169352)
1. Peyronie's disease is associated with Paget's disease of bone.
Lyles KW; Gold DT; Newton RA; Parekh S; Shipp KM; Pieper CF; Krishan R; Carson CC
J Bone Miner Res; 1997 Jun; 12(6):929-34. PubMed ID: 9169352
[TBL] [Abstract][Full Text] [Related]
2. Sarcoma arising in Paget's disease of bone: declining incidence and increasing age at presentation.
Mangham DC; Davie MW; Grimer RJ
Bone; 2009 Mar; 44(3):431-6. PubMed ID: 19064007
[TBL] [Abstract][Full Text] [Related]
3. Management of Peyronie's disease--a review.
Tunuguntla HS
World J Urol; 2001 Aug; 19(4):244-50. PubMed ID: 11550782
[TBL] [Abstract][Full Text] [Related]
4. Paget's disease of bone: experience from a centre in southern India.
Anjali ; Thomas N; Rajaratnam S; Shanthly N; Oommen R; Seshadri MS
J Assoc Physicians India; 2006 Jul; 54():525-9. PubMed ID: 17089899
[TBL] [Abstract][Full Text] [Related]
5. Incidence and natural history of Paget's disease of bone in England and Wales.
van Staa TP; Selby P; Leufkens HG; Lyles K; Sprafka JM; Cooper C
J Bone Miner Res; 2002 Mar; 17(3):465-71. PubMed ID: 11878305
[TBL] [Abstract][Full Text] [Related]
6. The treatment of loss of penile rigidity associated with Peyronie's disease.
Krane RJ
Scand J Urol Nephrol Suppl; 1996; 179():147-50. PubMed ID: 8908682
[TBL] [Abstract][Full Text] [Related]
7. Peyronie's disease: current management.
Fitkin J; Ho GT
Am Fam Physician; 1999 Aug; 60(2):549-52, 554. PubMed ID: 10465229
[TBL] [Abstract][Full Text] [Related]
8. Is the prevalence of Paget's disease of bone decreasing?
Cundy T
J Bone Miner Res; 2006 Dec; 21 Suppl 2():P9-13. PubMed ID: 17229016
[TBL] [Abstract][Full Text] [Related]
9. Basic fibroblast growth factor expression in Peyronie's disease.
Mulhall JP; Thom J; Lubrano T; Shankey TV
J Urol; 2001 Feb; 165(2):419-23. PubMed ID: 11176387
[TBL] [Abstract][Full Text] [Related]
10. Corrective procedures for penile shortening due to Peyronie's disease.
Rigaud G; Berger RE
J Urol; 1995 Feb; 153(2):368-70. PubMed ID: 7815586
[TBL] [Abstract][Full Text] [Related]
11. History, epidemiology, and clinical presentation of Peyronie's disease.
Hellstrom WJ
Int J Impot Res; 2003 Oct; 15 Suppl 5():S91-2. PubMed ID: 14551584
[TBL] [Abstract][Full Text] [Related]
12. Paget's disease of bone in New Zealand: continued decline in disease severity.
Cundy HR; Gamble G; Wattie D; Rutland M; Cundy T
Calcif Tissue Int; 2004 Nov; 75(5):358-64. PubMed ID: 15455187
[TBL] [Abstract][Full Text] [Related]
13. Prospective analysis of 16S rDNA as a highly sensitive marker for bacterial presence in Peyronie's disease plaques.
Hauck EW; Domann E; Hauptmann A; Weidner W; Chakraborty T; Hossain HM
J Urol; 2003 Nov; 170(5):2053-6. PubMed ID: 14532852
[TBL] [Abstract][Full Text] [Related]
14. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
Abelson A
Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
[TBL] [Abstract][Full Text] [Related]
15. Treatment of erectile dysfunction in patients with Peyronie's disease using sildenafil citrate.
Levine LA; Latchamsetty KC
Int J Impot Res; 2002 Dec; 14(6):478-82. PubMed ID: 12494281
[TBL] [Abstract][Full Text] [Related]
16. Familial aggregation of Paget's disease of bone.
Siris ES; Ottman R; Flaster E; Kelsey JL
J Bone Miner Res; 1991 May; 6(5):495-500. PubMed ID: 2068956
[TBL] [Abstract][Full Text] [Related]
17. Analysis of environmental factors in familial versus sporadic Paget's disease of bone--the New England Registry for Paget's Disease of Bone.
Seton M; Choi HK; Hansen MF; Sebaldt RJ; Cooper C
J Bone Miner Res; 2003 Aug; 18(8):1519-24. PubMed ID: 12929942
[TBL] [Abstract][Full Text] [Related]
18. Peyronie's Disease.
Taylor FL; Levine LA
Urol Clin North Am; 2007 Nov; 34(4):517-34, vi. PubMed ID: 17983892
[TBL] [Abstract][Full Text] [Related]
19. Tumor-associated Hypercalcemia in a patient with Paget's disease.
Hung HC; Ou HY; Huang JS; Chuang MC; Wu TJ
Kaohsiung J Med Sci; 2008 Mar; 24(3):152-6. PubMed ID: 18364276
[TBL] [Abstract][Full Text] [Related]
20. Should assessment of penetrative sexual activity be used as the treatment arbiter in the management of Peyronie's disease?
Dukic I; Thakare N; Pearce I; Payne SR
Int J Impot Res; 2011; 23(2):70-5. PubMed ID: 21430675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
